LONDON, August 1, 2014 /PRNewswire/ --

On Thursday, July 31, 2014, the NASDAQ Composite ended at 4,369.77, down 2.09%, the Dow Jones Industrial Average finished the day 1.88% lower at 16,563.30, and the S&P 500 closed at 1,930.67, down 2.00%. The losses were broad based as all the ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 704.37, down 2.03%, and the index has declined 0.02% in the last one month. Investor-Edge has initiated coverage on the following equities: MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Galena Biopharma Inc. (NASDAQ: GALE), Geron Corporation(NASDAQ: GERN), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research on these five companies can be accessed at:

http://investor-edge.com/register

On Thursday, MannKind Corp.'s stock recorded a trading volume of 5.46 million shares, lower than its three months average volume of 10.40 million shares. The stock finished the day at $8.36, down 3.46%, and registered an intraday range of $8.35 and $8.61. MannKind Corp.'s shares have lost 23.72% in the last one month. However, the stock has rallied 27.63% in the past three months and 60.77% on YTD basis. Furthermore, the company's shares are trading above their 200-day moving average. The stock's 50-day moving average of $9.66 is above its 200-day moving average of $6.64. Additionally, shares of MannKind Corp. have a Relative Strength Index (RSI) of 36.42. Sign up and read the free notes on MNKD at:

http://www.Investor-Edge.com/MNKD-01Aug2014

ARIAD Pharmaceuticals Inc.'s stock declined 5.88%, to close Thursday's session at an intra-day low of $5.76, after oscillating between $5.76 and $6.14. The stock recorded a trading volume of 6.30 million shares, below its three months average volume of 8.78 million shares. Over the last one month and past three months, ARIAD Pharmaceuticals Inc.'s shares have fallen by 9.58% and 20.77%, respectively. Also, from the beginning of 2014, the stock has declined 15.54%. The stock is trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $6.25 is above its 50-day moving average of $6.23. Further, ARIAD Pharmaceuticals Inc.'s stock has an RSI of 52.81. The complimentary notes on ARIA can be downloaded as in PDF format at:

http://www.Investor-Edge.com/ARIA-01Aug2014

On Thursday, shares in Galena Biopharma Inc. finished the session 4.05% lower at $2.84. A total of 1.63 million shares were traded, which was below its three months average volume of 3.17 million shares. The stock moved between $2.80 and $2.92 during the session. Over the last one month and since the start of this year, Galena Biopharma Inc.'s shares have gone down by 7.19% and 42.74%, respectively. However, the stock has surged 15.92% over the past three months. The company's shares are trading above their 50-day moving average. Moreover, the stock's 200-day moving average of $3.33 is greater than its 50-day moving average of $2.78. Shares of Galena Biopharma Inc. have an RSI of 54.39. Register for free on Investor-Edge and access the latest research on GALE at:

http://www.Investor-Edge.com/GALE-01Aug2014

Geron Corp.'s stock fluctuated between $2.40 and $2.45 before ending Thursday's session down 2.63%, at $2.41. The stock reported a trading volume of 1.72 million shares, below its three months average volume of 4.26 million shares. Further, Geron Corp.'s shares have advanced 0.63% over the past three trading sessions and 28.55% over the last three months. However, the stock has lost 46.30% on YTD basis. The stock is trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $3.39 is greater than its 50-day moving average of $2.51. Moreover, shares of Geron Corp. have an RSI of 42.80. The complete research on GERN is available for free at:

http://www.Investor-Edge.com/GERN-01Aug2014

Peregrine Pharmaceuticals Inc.'s stock fell by 2.58%, to close Thursday's session at $1.51, after vacillating between $1.50 and $1.56. The stock recorded a trading volume of 1.04 million shares, below its three months average volume of 1.24 million shares. Over the last one month and past three months, Peregrine Pharmaceuticals Inc.'s shares have plummeted 19.68% and 13.22%, respectively. However, from the beginning of 2014, the stock has gained 8.63%. The company's shares are trading below their 50-day and 200-day moving averages. The stock's 50-day moving average of $1.75 is above its 200-day moving average of $1.68. Further, Peregrine Pharmaceuticals Inc.'s stock has an RSI of 35.28. Free in depth research on PPHM is available at:

http://www.Investor-Edge.com/PPHM-01Aug2014

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

http://www.Investor-Edge.com

SOURCE Investor-Edge